Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Common Stock | Options Exercise | $315K | +10.5K | +93.96% | $30.17 | 21.6K | Feb 22, 2023 | Direct | F1 |
transaction | PFE | Common Stock | Tax liability | -$66.9K | -1.58K | -7.32% | $42.38 | 20K | Feb 22, 2023 | Direct | F2 |
transaction | PFE | Common Stock | Tax liability | -$278K | -6.37K | -31.82% | $43.70 | 13.6K | Feb 22, 2023 | Direct | F3, F4 |
transaction | PFE | Common Stock | Award | $0 | +3.1K | +22.75% | $0.00 | 16.7K | Feb 23, 2023 | Direct | F5 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Stock Appreciation Rights | Options Exercise | $0 | -10.5K | -100% | $0.00* | 0 | Feb 22, 2023 | Common Stock | 10.5K | $30.17 | Direct | |
transaction | PFE | Stock Appreciation Rights | Award | $0 | +12.2K | $0.00 | 12.2K | Feb 23, 2023 | Common Stock | 12.2K | $42.30 | Direct | F6 | |
transaction | PFE | Stock Appreciation Rights | Award | $0 | +10.6K | $0.00 | 10.6K | Feb 23, 2023 | Common Stock | 10.6K | $42.30 | Direct | F7 |
Id | Content |
---|---|
F1 | The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
F2 | The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. |
F3 | The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). |
F4 | Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
F5 | The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. |
F6 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |
F7 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. |